Recent News Releases

Jun 30, 2020
InMed Announces Completion of Share Consolidation

Trading of Consolidated Shares on TSX Expected to Begin on July 3rd, 2020 VANCOUVER, BC, June 30, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a...

Jun 24, 2020
InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Jun 19, 2020
InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

May 27, 2020
InMed Releases CBN Preclinical Results in Glaucoma

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

See All News Releases

Latest Presentation

Unlocking the Potential of Cannabinoid Medicines

Download pdf

Letter to Shareholders

Annual Letter to Shareholders 2020

January 17, 2020

Download pdf

Company Fact Sheet

Company Fact Sheet

September, 2019

Download pdf

SEDAR® Filings
Loading data...
Financial Reports

Quarterly and Annual Financial Results

2020

Third quarter, 2020 (quarter ended March 31, 2020)
Second quarter, 2020 (quarter ended December 31, 2019)
First quarter, 2020 (quarter ended September 30, 2019)

2019

AGM Documents
Fourth quarter, 2019 (full year ended June 30, 2019)
Third quarter, 2019 (quarter ended March 31, 2019)
Second quarter, 2019 (quarter ended December 31, 2018)
First quarter, 2019 (quarter ended September 30, 2018)

2018

AGM Documents
Fourth quarter, 2018 (full year ended June 30, 2018)
Third quarter, 2018 (quarter ended March 31, 2018)
Second quarter, 2018 (quarter ended December 31, 2017)
First quarter, 2018 (quarter ended September 30, 2017)

2017

Fourth quarter, 2017 (full year ended June 30, 2017)
Third quarter, 2017 (quarter ended March 31, 2017)
Second quarter, 2017 (quarter ended December 31, 2016)
First quarter, 2017 (quarter ended September 30, 2016)

Stock Performance

OTCQX: IMLFFTSX: IN
-
Loading...
Display Events
 
 
 
 
Chart Style
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings Events data provided by Wall Street Horizon.
OTCQX: IMLFFTSX: IN
Analyst Coverage
Firm Analyst E-mail Phone
Edison Investment Research Max Jacobs MJacobs@edisongroup.com +1 (646) 653-7027
Maxim Group, LLC Jason McCarthy, Ph.D. jmccarthy@maximgrp.com +1 (212) 895-3556
ROTH Capital Partners Scott R. Henry, CFA shenry@roth.com +1 (406) 425-0563